Research work · 2010

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Yung‐Jue Bang, Eric Van Cutsem, Andrea Feyereislova

The Lancet

Read free full text

DOI: 10.1016/s0140-6736(10)61121-x